Oxytocin injection the umblical vein for the management of the retained placenta

CONCLUSIONS: For the management of the third stage of delivery, oxytocin injection in to the umblical vein must be taken into consideration before any invasive aggressive procedure.

📌 3 Key Takeaways

🎯

Objective & Hypothesis:OBJECTIVE: To evaluate the value of oxytocin injection into umblical vein in the management of retained placenta, a major problem at the third stage of labor.

📊

Key Findings & Data:MATERIAL AND METHODS: During a six month period between January 1,1997-June 30,1997 we applied 50 Ü oxytocin in 15 cc 0,09 % NaCl solution in first 20 cases, only 0,09 % NaCl solution in second 20 cases of retained placenta.

💡

Conclusion & Impact:CONCLUSIONS: For the management of the third stage of delivery, oxytocin injection in to the umblical vein must be taken into consideration before any invasive aggressive procedure.

🔬Design:Research Article

📍Scope:Comprehensive Sample

⚙️Variables:Umbilikal venler · Plasenta · Oksitosin

Abstract

OBJECTIVE: To evaluate the value of oxytocin injection into umblical vein in the management of retained placenta, a major problem at the third stage of labor. MATERIAL AND METHODS: During a six month period between January 1,1997-June 30,1997 we applied 50 Ü oxytocin in 15 cc 0,09 % NaCl solution in first 20 cases, only 0,09 % NaCl solution in second 20 cases of retained placenta. In third 20 cases without massive hemorrhage, we waited for another 30 minutes. RESULTS: In the oxytocin injected cases, placenta was delivered in 4-8 minutes in all cases. On the other hand in 15 of 0,09 % NaCl administered cases placenta was delivered in 10-14 minutes. In 5 cases placenta was delivered at the end of 30 minutes manually . At the third group placenta was delivered spontaneously at the second 30 minutes in 13 cases and in 7 cases placenta was delivered manually. CONCLUSIONS: For the management of the third stage of delivery, oxytocin injection in to the umblical vein must be taken into consideration before any invasive aggressive procedure.

Özet

AMAÇ: Doğumun 3. devresinde önemli bir problem olan plasentanın ayrılmamasında umblikal vene oksitosin uygulamanın etkisini değerlendirmek. GEREÇ VE YÖNTEM: Doğumu takiben plasentası 30. dakikada ayrılmayan 20 olguda, 15 cc 0,9% NaCl solüsyonunda 50 İÜ oksitosin umblikal vene uygulandı. 20 olguluk ikinci grupta 15 cc %0,9 NaCl uygulandı 3. grupta ise kanaması olmayan 20 olguda ikinci bir 30 dakika daha beklendi. BULGULAR: Oksitosin uygulanan olguların tümünde plasenta 4 ile 8 dakika içerisinde ayrıldı. %0.9 NaCl uygulanan 15 olguda plasenta 10-14 dakika içinde spontan ayrılırken, 5 olguda plasenta 30 dakika sonunda manuel ayrıldı. 3. grupta 13 olguda plasenta 15 dakikada spontan ayrıldı. 7 olguda manuel ayrıldı. SONUÇ: Doğumun 3. Devresinde plasentanın ayrılması için agresif prosedürler uygulamadan evvel umblikal vene oksitosin uygulanması hatırlanmalıdır.

Keywords

Umbilikal venler Plasenta Oksitosin Doğum evresi üçüncü Doğum komplikasyonları Umbilical Veins Placenta Oxytocin Labor Stage Third Labor Complications

🔖

Cite This Article

SANCI, M., TURAN, E., MARAL, İ., KAÇAR, A., KURT, S., ŞEHİRALİ, S. (2000). Oxytocin injection the umblical vein for the management of the retained placenta. Medical Network Klinik Bilimler ve Doktor, Cilt: 6 - Sayı: 6, 790–792. https://ajindex.com/articles/278888

References (7)

Brandt ML. The mechanism and management of the third stage of labor Am. J. Obstet Gynecol 1933;25:622-7
Senatöre A. La Pituitnna endovena ombelicale nel mancato secondamento. Clin Obstet Ginecol 1953;5:305-9
Neri A, Goldman J, Gans B. İntraumblical vein injection of pitocin, a new method in the management of the third stage of labor 1966;70:351-5 4. Golan A, Lidor AL, Wexler S, David MP. Anew method for the management of the retained placenta Am. J. Obstet Gynecol 1983:146:708-9
Heinonen PK, Pikhala H. Pharmacologic management and controlled cord traction in the third stage of labor. Ann. Chir Gynaecol 1985;31 6. Wilken -Jensen C, Strom V, Dankjaer Nielsen M, Rosenkilde -Gram B: Removing a retained placenta by oxytocin - a controlled study A. J. Obstet Gynecol. 1989;161:155-6
Reddy W. Carey JC: Effect of umblical vein oxytocin on puerperal blood loss and length of the third stage of labor Am. J. Obstet Gynecol 1989;160:206-8
Danışman N. Beysanoğlu M, Çobanoğlu Ö, Moröy P, Gökmen O: Ayrılmayan plasentaların alınmasında vena umblikalisten oksitosin uygulanması. Türkiye Klinikleri Jinekoloji Obstet. 1993;2:126-8
Zeyneloğlu H, Mercan R, Deren Ö, Günalp S: İntraumblikal ven oksitosin uygulamasının puerperal kan kaybı ve eylemin 3. Evresine olan etkileri. Kadın Doğum Dergisi. 1993;1:4-6 10.Caroli G.: Management of retained plasenta by umblical vein injection BrJ.Obstet Gynecol. 1991;98:348-50. 11.Pipingas A, Hofmeyr J, Sesel K, Umblical vein oxytocin administration for retained placenta: In vitro study of various infusion techniques. Am. J. Obstet Gynecol 1993;168:793-5. 12.Parter KB, O'Brien WF, Collins MK: A randomized comparison of umblical vein and intravenous oxytocin during the puerperium. Obstet Gynecol: 1991;78 254-6. 13.Hanksson A.Oxytocin injection into the umblical vein in women with retained plasenta: a questionable method(letter). Am. J. Obstet Gynecol. 1986,155:1140. 14.Chestrut D, Wilcox L, Influence of umblical vein administration of oxytocin on the third stage of labor: a randomized double-blind placebo -controlled study. Am. J. Obstet Gynecol. 1987;157:160-2. 15.Kristiansen FV, Frost L, Kaspersen L, Moller BR. The effect of oxytocin injection into the umblical vein for the management of the retained plasenta Am. J. Obstet Gynecol 1987;156:979-80. 16.Huber MGP, Wildschut HU, Boer K, Kleirrerdo G, Hoek FJ. Umblical vein administration of oxytocin for the management of retained placenta: is it effective? Am.J. Obs